Gaining a better understanding of cardiorenal syndrome is essential for improving patient outcomes.
A new drug delivers significant treatment response in patients with difficult-to-treat metastatic triple-negative breast cancer.
Is there a benefit to using weekly methotrexate in giant cell arteritis patients who need to limit their glucocorticoid use?
We’ve created a transformative model for the health care industry that eliminates waste, improves coordination of care and helps us better manage chronic disease.
Baylor Scott & White has both clinical and research campuses for the Texas A&M Health Science Center (HSC) College of Medicine. In addition, we are an accredited provider for the Accreditation Council for Continuing Medical Education (ACCME).
Our extensive network of 48 hospitals and more than 900 patient care sites – including specialized centers, institutes and regional clinics – offers your patients a full range of medical expertise.
Can real-time audits and feedback about appropriate clinical indications for CVC use decreased CLABSI rates?
This conference will address critical issues related to decision-making for and treatment of stroke patients, as well as diagnosis and management of headaches.
This feasibility study will assess the effects of the Nativis Voyager therapy in patients with recurrent GBM who have either failed standard of care or are intolerant to therapy.